Intern DDIT APD AIP

Novartis is a Swiss pharmaceutical company created in 1996 by the merger of Ciba-Geigy and Sandoz, two Basel chemical and drug houses with roots in the nineteenth century. It has spent the past decade narrowing itself into a pure innovative medicines business, spinning off its generics arm as Sandoz in 2023 and its eye care business as Alcon in 2019, and now concentrates on cardiovascular, immunology, neuroscience and oncology, including radioligand therapies and gene therapy. Headquartered in Basel and listed in Zurich and New York, it is among the largest research spenders in the industry.